Venus Acquisition - Tradeable Rights - April 2021 EBIT

As of the most recent data (December 2025), VENAR shows a EBIT of $720K. That compares with $2.8M in the prior-year period — down 74.5% year over year. That is above the sector sector average of $-6.4M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VENAR's EBIT is now $720K (was $2.8M) — a 74.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Venus Acquisition - Tradeable Rights - April 2021 is outperforming or lagging.

The its sector sector average EBIT is about $-6.4M. Venus Acquisition - Tradeable Rights - April 2021 is at $720K, which is higher that average. That is roughly 111.2% above the sector mean. Use the comparison chart on this page to see how VENAR stacks up against individual peers as well.

Tracking VENAR's ebit over time shows whether Venus Acquisition - Tradeable Rights - April 2021 is scaling, shrinking, or reshaping that part of the business. The current reading is $720K That compares with $2.8M in the prior-year period — down 74.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Venus Acquisition - Tradeable Rights - April 2021's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $720K) with ownership activity and broader fundamentals.